Coronavirus outbreak: the impact on emerging-market equities

In the wake of the sharp decline we've seen across emerging-market equities and global markets amid growing concern about the coronavirus, it should be remembered that China and parts of Asia have been laboring with the ramifications of the outbreak since the beginning of the year.

Coronavirus outbreak: the impact on emerging-market equities

The market reactions of the past few days appear to have been triggered by the realization that global supply chains may be affected—and that things are coming closer to home, from a Western perspective, with infection rates picking up.  

From our perspective, this is a watershed for public health, with the spread beyond China triggering an exogenous shock necessitating reassessment of the economic and corporate risks globally.  

These center on impacts on growth and profitability arising from:

·         Reduction in demand, not just in China, but with abrupt disruption to travel, leisure, and retail globally

·         Manufacturing companies with factories in—or dependent on—China

·         Supply chain disruption and delayed product launches following prolonged factory closures, affecting critical components and trade flows across Asia

·         Commodity-exposed companies (e.g., metals, energy)

·         Consumer companies hit by low footfall, wage cuts

·         Second-order impacts as cash flow problems escalate

The playbook from previous virus outbreaks had encouraged the view that the impact would be temporary, with short-term weakness to be followed by a strong rebound in subsequent quarters given suppressed demand, inventory rundown, and counterbalancing policy actions. This, in our view, had led to a degree of complacency, as easing financial conditions and lower bond yields provided crucial support to offset growth fears. 

However, and whenever this outbreak peaks, recovery will not be linear, and the consequences will be far-reaching, with negative and positive implications for policy, human behavior, and complex supply chains. Lower Chinese exports will affect a wide range of categories, including autos, textiles, and pharmaceuticals (75% of antibiotics imported into India, for example, come from China).1 But there may also be export share gains for vertically integrated companies, and the impact will be to further encourage the diversification of global supply chains and the drive to self-sufficiency, trends that were both stimulated by the trade war of the last two years.

Within China, the effect is likely to accelerate structural changes already in place, enabled by technology. The need for improvements in public health infrastructure will encourage faster development of smart cities, enabled by the Internet of Things with the accelerated deployment of 5G already under way. Industrial automation will increasingly replace physical labor, not just in manufacturing but in delivery. Individual behavior will change: the use of more apps, more home delivery, the move from offline to online shopping, entertainment, healthcare, and education.

In our view, the acceleration of these secular changes creates long-term opportunities for astute entrepreneurship and innovation across a range of industries and emerging markets. That said, care is needed to manage entry points during this period of extreme market volatility to invest in businesses that are poised to emerge strongly from this period of uncertainty. 

1 Chinese cheer for Indian exports,” The Hindu, March 4, 2019

Investing involves risks, including the potential loss of principal. Financial markets are volatile and can fluctuate significantly in response to company, industry, political, regulatory, market, or economic developments. These risks are magnified for investments made in emerging markets. Currency risk is the risk that fluctuations in exchange rates may adversely affect the value of a portfolio’s investments.

The information provided does not take into account the suitability, investment objectives, financial situation, or particular needs of any specific person. You should consider the suitability of any type of investment for your circumstances and, if necessary, seek professional advice.

This material, intended for the exclusive use by the recipients who are allowable to receive this document under the applicable laws and regulations of the relevant jurisdictions, was produced by, and the opinions expressed are those of, Manulife Investment Management as of the date of this publication, and are subject to change based on market and other conditions. The information and/or analysis contained in this material have been compiled or arrived at from sources believed to be reliable, but Manulife Investment Management does not make any representation as to their accuracy, correctness, usefulness, or completeness and does not accept liability for any loss arising from the use of the information and/or analysis contained. The information in this material may contain projections or other forward-looking statements regarding future events, targets, management discipline, or other expectations, and is only as current as of the date indicated. The information in this document, including statements concerning financial market trends, are based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Manulife Investment Management disclaims any responsibility to update such information.

Neither Manulife Investment Management or its affiliates, nor any of their directors, officers or employees shall assume any liability or responsibility for any direct or indirect loss or damage or any other consequence of any person acting or not acting in reliance on the information contained herein.  All overviews and commentary are intended to be general in nature and for current interest. While helpful, these overviews are no substitute for professional tax, investment or legal advice. Clients should seek professional advice for their particular situation. Neither Manulife, Manulife Investment Management, nor any of their affiliates or representatives is providing tax, investment or legal advice. Past performance does not guarantee future results. This material was prepared solely for informational purposes, does not constitute a recommendation, professional advice, an offer or an invitation by or on behalf of Manulife Investment Management to any person to buy or sell any security or adopt any investment strategy, and is no indication of trading intent in any fund or account managed by Manulife Investment Management. No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment. Diversification or asset allocation does not guarantee a profit nor protect against loss in any market. Unless otherwise specified, all data is sourced from Manulife Investment Management.

Manulife Investment Management

Manulife Investment Management is the global wealth and asset management segment of Manulife Financial Corporation. We draw on more than 150 years of financial stewardship to partner with clients across our institutional, retail, and retirement businesses globally. Our specialist approach to money management includes the highly differentiated strategies of our fixed-income, specialized equity, multi-asset solutions, and private markets teams—along with access to specialized, unaffiliated asset managers from around the world through our multimanager model.

These materials have not been reviewed by, are not registered with any securities or other regulatory authority, and may, where appropriate, be distributed by the following Manulife entities in their respective jurisdictions. Additional information about Manulife Investment Management may be found at www.manulifeam.com.

Australia: Hancock Natural Resource Group Australasia Pty Limited, Manulife Investment Management (Hong Kong) Limited. Brazil: Hancock Asset Management Brasil Ltda. Canada: Manulife Investment Management Limited, Manulife Investment Management Distributors Inc., Manulife Investment Management (North America) Limited, Manulife Investment Management Private Markets (Canada) Corp. China: Manulife Overseas Investment Fund Management (Shanghai) Limited Company. European Economic Area and United Kingdom: Manulife Investment Management (Europe) Ltd. which is authorised and regulated by the Financial Conduct Authority, Manulife Investment Management (Ireland) Ltd. which is authorised and regulated by the Central Bank of Ireland Hong Kong: Manulife Investment Management (Hong Kong) Limited. Indonesia: PT Manulife Aset Manajemen Indonesia. Japan: Manulife Asset Management (Japan) Limited. Malaysia: Manulife Investment Management (M) Berhad (formerly known as Manulife Asset Management Services Berhad) 200801033087 (834424-U) Philippines: Manulife Asset Management and Trust Corporation. Singapore: Manulife Investment Management (Singapore) Pte. Ltd. (Company Registration No. 200709952G) Switzerland: Manulife IM (Switzerland) LLC. Taiwan: Manulife Investment Management (Taiwan) Co. Ltd. Thailand: Manulife Asset Management (Thailand) Company Limited. United States: John Hancock Investment Management LLC, Manulife Investment Management (US) LLC, Manulife Investment Management Private Markets (US) LLC and Hancock Natural Resource Group, Inc. Vietnam: Manulife Investment Fund Management (Vietnam) Company Limited.

Manulife Investment Management, the Stylized M Design, and Manulife Investment Management & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and are used by it, and by its affiliates under license.

 

 

510517

Kathryn Langridge

Kathryn Langridge, 

Co-Head, Senior Portfolio Manager, Emerging Markets Equity

Manulife Investment Management

Read bio
Philip Ehrmann

Philip Ehrmann, 

Former Senior Portfolio Manager, Emerging Markets Equity

Manulife Investment Management

Read bio